Can You Die From a Muscle Relaxer Overdose?

Muscle relaxer overdose can kill, though the risk varies enormously depending on which drug is involved, how much is taken, and what other substances are in the person’s system. A single-agent overdose of one of the more common prescription muscle relaxants has a relatively low fatality rate compared to, say, opioids or barbiturates. But “relatively low” is not zero, and certain muscle relaxants carry genuinely dangerous margins between a therapeutic dose and a lethal one. The picture gets far worse when other depressant drugs enter the mix.

Not All Muscle Relaxants Carry the Same Risk

The category “muscle relaxant” covers a surprisingly diverse group of medications that work through different mechanisms and carry very different overdose profiles. Cyclobenzaprine, one of the most widely prescribed, is structurally similar to tricyclic antidepressants and shares their potential to interfere with the heart’s electrical signaling. In overdose, cyclobenzaprine can block sodium channels in the heart and trigger dangerous rhythm disturbances, though cardiac toxicity from cyclobenzaprine alone is considered rare.¹ Because of this structural similarity, emergency rooms treat cyclobenzaprine overdose using the same protocols developed for tricyclic antidepressant poisoning.²

Orphenadrine sits at the more dangerous end of the spectrum. It has strong anticholinergic effects, and ingestion of just two to three grams in an adult has been associated with fatal outcomes.³ That is a strikingly narrow gap between a normal dose and a potentially lethal one. A retrospective poisons-center study found that all patients in their series survived orphenadrine self-poisoning without severe cardiac or neurological toxicity, but the authors noted this contrasts with published case reports documenting severe poisoning at similar or even lower doses.⁴ Individual variation plays a real role here: what one person walks away from can be catastrophic for someone else.

Tizanidine, commonly prescribed for spasticity, acts on the central nervous system in a way that can profoundly slow the heart and crash blood pressure. In one documented case, a woman who took 24 mg of tizanidine was found by paramedics with a heart rate of 30 beats per minute and blood pressure so low it couldn’t be measured.⁵ That is not a massive overdose by the standards of most drugs, yet it triggered cardiovascular collapse requiring intensive care.

Carisoprodol presents its own set of problems. The body breaks it down into meprobamate, an older sedative that acts much like a barbiturate. Forensic toxicology data suggest that when carisoprodol is taken alongside other medications, it can contribute to death even when blood levels are technically within the therapeutic range. Blood concentrations above roughly 15 mg/L and liver concentrations above 50 mg/kg are considered excessive and potentially fatal.⁶ That finding is unsettling because it means you don’t necessarily need to take a huge amount for the drug to play a role in a death.

The Real Killer Is Often Polypharmacy

The single most important thing to understand about muscle relaxant fatalities is that the danger multiplies when other central nervous system depressants are involved. Opioids, benzodiazepines, and alcohol all slow breathing and suppress consciousness through overlapping pathways. Add a muscle relaxant on top of one or more of these, and the combined effect can push a person past the threshold their body can tolerate.

A large population-based study found that people taking opioids alongside muscle relaxants at daily opioid doses of 50 mg or more had a roughly 50 percent higher risk of opioid overdose. Those who were also taking benzodiazepines had about a 39 percent higher risk.⁷ The clinical picture in these cases is grim: breathing slows until it stops, and without immediate intervention, the person dies.

Not all muscle relaxants contribute equally to this risk when paired with opioids. A comparative study found that baclofen carried the highest relative risk of opioid overdose compared to cyclobenzaprine as a reference, with a hazard ratio of about 2.5. Carisoprodol was intermediate, while metaxalone appeared to have the lowest risk.⁸ If you’re taking opioids and your doctor prescribes a muscle relaxant, the specific one chosen actually matters for your safety. This is not a category where all options are interchangeable.

Older research looking at poison control data reached a conclusion that still holds up: mortality from pure, single-agent muscle relaxant ingestion is low, but it climbs when multiple substances are involved.⁷ Many of the deaths attributed to muscle relaxants in forensic and toxicology reports involve alcohol, opioids, or benzodiazepines as co-ingestants. A person taking their prescribed muscle relaxant as directed is in a fundamentally different risk category from someone who takes a handful of pills after drinking.

Baclofen Deserves Special Attention

Baclofen is in some ways the most treacherous of the commonly prescribed muscle relaxants, and it causes trouble in two directions: overdose and withdrawal. It works by mimicking a neurotransmitter that inhibits nerve activity, and in overdose, it can suppress brain function to a startling degree.

A review of pediatric baclofen poisoning cases found that children who ingested doses ranging from 20 mg to over 2,000 mg presented with coma, dangerously slow heart rates, low blood pressure, seizures, and abnormally low body temperature.⁹ The blood levels measured across these cases varied enormously, from undetectable to very high, which means you cannot predict toxicity from dose alone. Some children became critically ill from relatively modest amounts.

The withdrawal side of baclofen is equally alarming. People who have been taking baclofen regularly and stop abruptly can develop severe psychiatric disturbances, delirium, agitation, and autonomic instability, where the body loses its ability to regulate heart rate, blood pressure, and temperature. A systematic review found that these symptoms typically emerge within one to four days of stopping the drug and can become life-threatening.¹⁰ Baclofen therapy in general carries the potential for both life-threatening toxicity from too much and life-threatening withdrawal from too little.¹¹ This puts patients who use baclofen long-term in a position where they need medical guidance to adjust their dose in either direction.

Children and Older Adults Face Higher Risk

Accidental ingestion by young children is a persistent hazard with muscle relaxants, particularly baclofen. A case report of a three-year-old who accidentally swallowed baclofen described the child falling into a coma with a dangerously slow heart rate and low blood pressure.¹² Children are more vulnerable partly because of their smaller body weight, which means even a single adult-dose tablet can produce toxic blood levels. The authors of that case stressed the need to warn families when baclofen is prescribed to any household member, because small children will find and eat pills.

Older adults face a different kind of danger. A study of over 300,000 adults aged 65 and older found that those using any skeletal muscle relaxant had about a third higher odds of sustaining an injury compared to non-users. Carisoprodol was the worst offender, associated with a 73 percent increase in injury risk, followed by methocarbamol and cyclobenzaprine.¹³ These injuries, primarily falls, are themselves a major source of mortality in the elderly. A hip fracture in an 80-year-old can set off a cascade of complications that ends in death, even if the muscle relaxant itself didn’t directly cause a fatal overdose. Sedation, impaired coordination, and dizziness from muscle relaxants turn routine activities like getting up at night into genuine hazards.

Older adults also tend to take more medications overall, which raises the polypharmacy risk discussed earlier. An older person on a muscle relaxant, a benzodiazepine for anxiety, and a low-dose opioid for chronic pain is sitting on a combination that can suppress breathing during sleep.

What an Overdose Actually Looks Like

The symptoms of muscle relaxant overdose depend on the specific drug but share a common theme: the central nervous system shuts down progressively. Early signs often include extreme drowsiness, confusion, slurred speech, and loss of coordination. As the overdose worsens, breathing becomes shallow, the heart rate drops, blood pressure falls, and the person may lose consciousness entirely.

Seizures are a feature of baclofen and sometimes cyclobenzaprine overdose. Cardiac rhythm disturbances, as mentioned earlier, are primarily a concern with cyclobenzaprine and orphenadrine. Tizanidine tends to produce profound drops in heart rate and blood pressure. The person may look asleep but be in a medical emergency. One of the deceptive things about CNS depressant overdose is that it can resemble deep sleep to a bystander, especially in the early stages.

If you find someone you suspect has overdosed on a muscle relaxant, call emergency services immediately. Do not wait to see if they “sleep it off.” The transition from dangerously sedated to not breathing can happen without any outward drama.

How Emergency Rooms Handle It

There is no specific antidote for most muscle relaxant overdoses. Treatment is supportive, meaning the medical team works to keep the patient alive while the drug clears the body. For cyclobenzaprine, emergency physicians follow the same protocols used for tricyclic antidepressant overdose, which typically includes intravenous sodium bicarbonate to counteract cardiac sodium channel blockade.²

For baclofen, a study of adolescents who intentionally took large doses found that all patients received activated charcoal, and various supportive medications were administered depending on symptoms: drugs to raise blood pressure, anti-seizure medications, and in some cases naloxone (the opioid-reversal drug, tried because baclofen’s effects mimic opioid overdose in some ways). All patients in that series recovered and went home within five days.¹⁴ The fact that they all survived with aggressive hospital care underscores the point: these overdoses are survivable with prompt treatment. The people who die are often those who don’t reach medical care in time, or whose overdose involves multiple drugs that compound each other’s effects.

Mechanical ventilation, where a machine breathes for the patient, is sometimes necessary when respiratory depression is severe. Vasopressor drugs to support blood pressure, continuous heart monitoring, and intensive care observation are all standard parts of the response. The length of hospital stay depends on the drug’s half-life and how quickly the body clears it.

Why Prescribing Patterns Matter

One underappreciated aspect of muscle relaxant safety is that prescribing decisions often don’t account for the full risk picture. Many physicians treat muscle relaxants as a homogeneous class, prescribing whichever one they’re most familiar with or whichever the patient’s insurance covers. But the evidence shows clear differences in risk profiles. Baclofen paired with opioids carries roughly two and a half times the overdose risk that cyclobenzaprine does in the same combination.⁸ Orphenadrine has a narrow window between help and harm.³ Carisoprodol carries abuse potential because of its conversion to meprobamate. These aren’t trivial distinctions for someone who is also taking other medications.

If you’re prescribed a muscle relaxant, it’s worth asking your doctor or pharmacist whether it’s the safest option given whatever else you take. If you take opioids, benzodiazepines, or drink alcohol with any regularity, that conversation isn’t optional. And if you live with children or cognitively impaired adults, keeping muscle relaxants locked away or in child-resistant storage isn’t being paranoid; it’s responding to a documented hazard.

Carisoprodol and the Abuse Question

Carisoprodol occupies an unusual niche among muscle relaxants because it is actively abused for its sedative and euphoric effects. Its metabolite, meprobamate, was itself once a widely prescribed tranquilizer before being recognized as habit-forming. When carisoprodol is taken in large doses or combined with other depressants, the meprobamate buildup can produce barbiturate-like toxicity. Forensic data show that carisoprodol can contribute to death even at concentrations that might look normal on a standard toxicology screen, particularly when other substances are present.⁶

This is one reason carisoprodol has been reclassified as a controlled substance in many jurisdictions. People who develop tolerance and escalate their doses are walking toward a cliff, particularly if they combine carisoprodol with alcohol or opioids for a stronger effect. The injury risk in older adults taking carisoprodol was the highest of any muscle relaxant studied, nearly 73 percent above baseline.¹³ The drug’s abuse potential and its pharmacological quirks make it one that many pain specialists now avoid prescribing when alternatives exist.

Newer Agents and the Search for Safer Options

Research into muscle relaxants that are less dangerous in overdose has been ongoing for decades, with mixed results. Tolperisone, widely used in parts of Europe and Asia, works by blocking voltage-gated sodium channels with some effect on calcium channels.¹⁵ It causes less sedation than many of the older relaxants, which in theory should translate to a wider safety margin. But it remains unavailable in the United States, and the evidence base for comparing its overdose toxicity to established drugs remains thin.

Metaxalone is sometimes positioned as a safer choice because of its lower sedative potential, and the comparative study on opioid overdose risk found it had the lowest hazard ratio of any muscle relaxant studied when used alongside opioids.⁸ For patients who genuinely need a muscle relaxant and are also taking opioids, this kind of data should inform the choice. The ideal muscle relaxant, one that relieves spasm without depressing consciousness or breathing, doesn’t quite exist yet, but the options are not all equally risky, and pretending they are costs lives.

1
PubMed. Cardiac sodium channel blockade after an intentional ingestion of lacosamide, cyclobenzaprine, and levetiracetam: Case report
2
PubMed. Overdose of cyclobenzaprine, the tricyclic muscle relaxant
3
PubMed. Full recovery from a potentially lethal dose of orphenadrine ingestion using conservative treatment: a case report
4
PubMed. Clinical outcomes associated with orphenadrine deliberate self-poisoning: a retrospective poisons centre study
5
PubMed Central. Emergency Response to Tizanidine Overdose: A Case Report on Critical Care Strategies
6
PubMed. Postmortem carisoprodol and meprobamate concentrations in blood and liver: lack of significant redistribution
7
PubMed. Risk of Opioid Overdose Associated With Concomitant Use of Opioids and Skeletal Muscle Relaxants: A Population-Based Cohort Study
8
PubMed. Comparative Risk of Opioid Overdose With Concomitant Use of Prescription Opioids and Skeletal Muscle Relaxants
9
Journal of Pediatric Emergency and Intensive Care Medicine. Recognizing and Managing Life-threatening Toxicity in Pediatric Baclofen Poisoning: A Case Report
10
PubMed. Clinical Presentations and Treatment of Baclofen Toxicity and Withdrawal: A Systematic Review
11
PubMed Central. Baclofen therapeutics, toxicity, and withdrawal: A narrative review
12
PubMed Central. Baclofen intoxication after accidental ingestion in a 3-year-old child
13
PubMed. Risk of injury associated with skeletal muscle relaxant use in older adults
14
PubMed. Baclofen overdose: drug experimentation in a group of adolescents
15
PubMed Central. Centrally Acting Skeletal Muscle Relaxants Sharing Molecular Targets with Drugs for Neuropathic Pain Management